Eric Daar
Chief · University of Southern California/Los Angeles General Medical Center
Credentials: · · ·
History
1988–1990- 1985–1988
Internal Medicine

Research
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Science · 2010 · 997 citations
Antiretroviral-drug resistance among patients recently infected with HIV
New England Journal of Medicine · 2002 · 929 citations
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
New England Journal of Medicine · 2021 · 759 citations

57 papers

54 papers

51 papers

47 papers

46 papers

35 papers

33 papers
- AJ
32 papers
Grants
- 2023–2028
National Institute on Minority Health and Health Disparities · R01
PI · $4.5M · University of California Los Angeles
- 2015–2023
Measuring and Monitoring Adherence to ART with Pill Ingestion Sensor System
National Institute of Mental Health · R01
PI · $4M · University of California Los Angeles
- 1997–2010
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $6.6M · Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
Clinical trials
- 2006–2012
Principal investigator · Completed · Phase 4
University of California, San Diego
- 1999–2007
Outcomes of Anti-HIV Therapy During Early HIV Infection
Principal investigator · Completed
National Institute of Allergy and Infectious Diseases (NIAID)
- 1999–2008
The Biology of HIV Transmission
Principal investigator · Completed
National Institute of Allergy and Infectious Diseases (NIAID)
- 2005–2009
Study chair · Completed · Phase 3
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections


